We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+21.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.2B
AUM Growth
+$6.6B
Cap. Flow
+$3.75B
Cap. Flow %
16.89%
Top 10 Hldgs %
18.16%
Holding
1,735
New
565
Increased
342
Reduced
340
Closed
467

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$239M
2
AAPL icon
Apple
AAPL
+$213M
3
ELV icon
Elevance Health
ELV
+$188M
4
BMY icon
Bristol-Myers Squibb
BMY
+$184M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$166M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$183M
2
ABBV icon
AbbVie
ABBV
+$149M
3
HUM icon
Humana
HUM
+$120M
4
FIS icon
Fidelity National Information Services
FIS
+$119M
5
MELI icon
Mercado Libre
MELI
+$103M

Sector Composition

Rank Sector Weight
1 Healthcare 27.33%
2 Technology 17.93%
3 Consumer Discretionary 11.98%
4 Financials 8.85%
5 Communication Services 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TT icon
226
Trane Technologies
TT
$107B
$22.6M 0.1%
156,002
-155,488
-50% -$21.5M
AGCO icon
227
AGCO
AGCO
$7.15B
$22.6M 0.1%
+219,260
New +$19.5M
NSC icon
228
Norfolk Southern
NSC
$75.3B
$22.6M 0.1%
95,060
-56,061
-37% -$12.8M
DELL icon
229
Dell
DELL
$298B
$22.5M 0.1%
605,271
+583,525
+2,683% +$20.3M
TXN icon
230
Texas Instruments
TXN
$260B
$22.5M 0.1%
+136,931
New +$21.3M
CVNA icon
231
Carvana
CVNA
$78.2B
$22.5M 0.1%
+468,890
New +$21.4M
CLDX icon
232
Celldex Therapeutics
CLDX
$3.31B
$22.5M 0.1%
1,281,624
+1,026,901
+403% +$18.5M
CVS icon
233
CVS Health
CVS
$123B
$22.3M 0.1%
326,985
-678,967
-67% -$44.2M
JD icon
234
JD.com
JD
$44.6B
$22.2M 0.1%
252,998
+227,241
+882% +$19M
SWKS icon
235
Skyworks Solutions
SWKS
$10.6B
$22.2M 0.1%
+145,233
New +$21.3M
TFC icon
236
Truist Financial
TFC
$63.6B
$22.1M 0.1%
+462,069
New +$20.9M
RL icon
237
Ralph Lauren
RL
$24.1B
$22M 0.1%
+212,386
New +$17.8M
AON icon
238
Aon
AON
$75.6B
$21.5M 0.1%
+101,788
New +$20.8M
VMI icon
239
Valmont Industries
VMI
$9.57B
$21.4M 0.1%
122,517
-3,404
-3% -$530K
SHOP icon
240
Shopify
SHOP
$193B
$21.4M 0.1%
189,350
+25,920
+16% +$2.72M
OKTA icon
241
Okta
OKTA
$26.1B
$21.3M 0.1%
83,877
+73,269
+691% +$17.4M
RY icon
242
Royal Bank of Canada
RY
$294B
$21.2M 0.1%
258,237
-256,422
-50% -$19.8M
HPQ icon
243
HP
HPQ
$28.1B
$21.1M 0.1%
858,671
+766,805
+835% +$16.1M
F icon
244
Ford
F
$55.4B
$21M 0.09%
2,388,244
+1,651,527
+224% +$13.8M
TROX icon
245
Tronox
TROX
$1.03B
$21M 0.09%
1,435,203
-699,351
-33% -$8.14M
BCRX icon
246
BioCryst Pharmaceuticals
BCRX
$2.39B
$20.8M 0.09%
2,798,523
+1,317,865
+89% +$6.79M
ENS icon
247
EnerSys
ENS
$6.98B
$20.8M 0.09%
250,501
-129,037
-34% -$10.1M
BBL
248
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$20.7M 0.09%
390,964
+225,709
+137% +$10.4M
IPOF.U
249
DELISTED
Social Capital Hedosophia Holdings Corp. VI Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
IPOF.U
$20.5M 0.09%
+1,589,903
New +$17.4M
FHI icon
250
Federated Hermes
FHI
$4.72B
$20.5M 0.09%
708,130
-145,011
-17% -$3.86M
8 9
10
11 12

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace North America held 1,735 positions worth $22.2B, up 42% from $15.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $3.75B of net new capital in Q4 2020, opening 565 new positions and adding to 342 existing holdings. Its largest new stake was ExxonMobil: 2,686,885 shares worth $111M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Adobe, an estimated $183M trimmed.

  • Marshall Wace North America's largest Q4 2020 buy was ExxonMobil: 2,686,885 shares worth $111M.
  • Marshall Wace North America added most to Thermo Fisher Scientific in Q4 2020, an estimated $239M increase.
  • Marshall Wace North America's biggest Q4 2020 reduction was Adobe, cutting an estimated $183M.
  • Marshall Wace North America fully exited Baxter International in Q4 2020, selling an estimated $92.8M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $22.2B portfolio in Q4 2020.
  • Marshall Wace North America opened 565 new positions and closed 467 in Q4 2020.
  • Marshall Wace North America's portfolio value rose 42% quarter-over-quarter to $22.2B.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.